Ioannis Sotiropoulos
Overview
Explore the profile of Ioannis Sotiropoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pickering G, OKeeffe M, Bannister K, Becker S, Cottom S, Cox F, et al.
Eur J Pain
. 2024 Dec;
29(1):e4767.
PMID: 39655849
Background: Pain is the leading cause of disability and reduced quality of life worldwide. Despite the increasing burden for patients and healthcare systems, pain research remains underfunded and under focused....
2.
Burke M, Sotiropoulos I, Waites C
Trends Neurosci
. 2024 Sep;
47(11):933-948.
PMID: 39307629
Chronic stress and the accompanying long-term elevation of glucocorticoids (GCs), the stress hormones of the body, increase the risk and accelerate the progression of Alzheimer's disease (AD). Signatures of AD...
3.
Brakatselos C, Polissidis A, Ntoulas G, Asprogerakas M, Tsarna O, Vamvaka-Iakovou A, et al.
Neuropsychopharmacology
. 2024 Sep;
50(2):388-400.
PMID: 39242923
Repeated administration of ketamine (KET) has been used to model schizophrenia-like symptomatology in rodents, but the psychotomimetic neurobiological and neuroanatomical underpinnings remain elusive. In parallel, the unmet need for a...
4.
Basso M, Gori A, Nardella C, Palviainen M, Holcar M, Sotiropoulos I, et al.
J Extracell Biol
. 2024 Feb;
3(1).
PMID: 38405579
The 'QuantitatEVs: multiscale analyses, from bulk to single vesicle' workshop aimed to discuss quantitative strategies and harmonized wet and computational approaches toward the comprehensive analysis of extracellular vesicles (EVs) from...
5.
Wang H, Siow R, Schmauck-Medina T, Zhang J, Sandset P, Filshie C, et al.
J Gerontol A Biol Sci Med Sci
. 2024 Jan;
79(4).
PMID: 38289789
Unhealthy aging poses a global challenge with profound healthcare and socioeconomic implications. Slowing down the aging process offers a promising approach to reduce the burden of a number of age-related...
6.
Yu Q, Du F, Belli I, Gomes P, Sotiropoulos I, Waites C
Cell Death Dis
. 2024 Jan;
15(1):73.
PMID: 38238309
Chronic stress and elevated levels of glucocorticoids (GCs), the main stress hormones, accelerate Alzheimer's disease (AD) onset and progression. A major driver of AD progression is the spreading of pathogenic...
7.
Hodes G, Bangasser D, Sotiropoulos I, Kokras N, Dalla C
Curr Neuropharmacol
. 2023 Oct;
22(3):475-494.
PMID: 37855285
Neuropsychiatric disorders, which are associated with stress hormone dysregulation, occur at different rates in men and women. Moreover, nowadays, preclinical and clinical evidence demonstrates that sex and gender can lead...
8.
Dioli C, Papadimitriou G, Megalokonomou A, Marques C, Sousa N, Sotiropoulos I
Adv Exp Med Biol
. 2023 Jul;
1423:303-315.
PMID: 37525058
Chronic stress and high levels of the main stress hormones, and glucocorticoids (GC), are implicated in susceptibility to brain pathologies such as depression and Alzheimer's disease (AD), as they promote...
9.
Waites C, Yu Q, Du F, Belli I, Gomes P, Sotiropoulos I
Res Sq
. 2023 Jul;
PMID: 37503224
Chronic stress and elevated levels of glucocorticoids (GCs), the main stress hormones, accelerate Alzheimer's disease (AD) onset and progression. A major driver of AD progression is the spreading of pathogenic...
10.
Yu Q, Du F, Belli I, Gomes P, Sotiropoulos I, Waites C
bioRxiv
. 2023 Jun;
PMID: 37333306
Chronic stress and elevated levels of glucocorticoids (GCs), the main stress hormones, accelerate Alzheimer's disease (AD) onset and progression. A major driver of AD progression is the spreading of pathogenic...